Very successful fund Baupost owns Facet Biotech (FACT). Facet is a $420 million market capitalization biotech company. A classic value-investor setup that was a spinoff from parent PDL Biopharma (PDLI) in December 2008. Facet contains the former R&D… More
Repost of a blog.Examining Facet BiotechQ: There's been a lot of talk about Facet Biotech (FACT). Why is this company generating discussion?A: Facet is the spinoff of PDL Biopharma (PDLI), which was created to give investors a shot at PDL's drug… More
Fools bearish on FACT.DL
are also bearish on: